Liana Moussatos Joins A Slew of Analysts That Are Gaining More Confidence in Xoma
Catabasis Pharmaceuticals (NASDAQ:CATB) investors endured a roller coaster ride in a just a few hours, after the drug maker shared results for Edasalonexent …
Catabasis Pharmaceuticals Inc (NASDAQ:CATB) shares are falling 16% today after having just risen approximately 80% last week, placing the biotech stock in full …
Analysts from BTIG and Webush are sharing insights on two falling stocks: Imperva Inc (NYSE:IMPV), whose shares are crashing close to 15% today, and …
XOMA Corp (NASDAQ:XOMA) recently released initial data from its single-dose trials for XOMA 358, the firm’s pipeline drug designed to treat rare endocrine …
In a research report published Wednesday, Wedbush analyst Liana Moussatos downgraded shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE) from Outperform to Neutral, while reducing the …
Omeros Corporation (NASDAQ:OMER) shares tumbled nearly 12% today, after the company announced a $40-million underwritten public offering of its common stock at a …
Wedbush analyst Liana Moussatos weighs in on Relypsa Inc (NASDAQ:RLYP), following the news that Switzerland’s Galenica Group has agreed to buy Relypsa for $32 …
In a research note released Friday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE), while raising the …
Liana Moussatos of Wedbush rates stocks in the biotechnology sector and is one of the top 50 analysts rated on TipRanks. Today, Moussatos reiterated ratings for …
